Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 139

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

298	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/30/2014 9:40:14 AM
297	NVLX news:	stocklegend	01/30/2014 9:23:35 AM
296	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/30/2014 8:47:34 AM
295	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/29/2014 3:58:37 PM
294	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/29/2014 2:11:23 PM
293	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/29/2014 2:01:12 PM
292	$NVLX Nuvilex Accelerates Development of	stocklegend	01/29/2014 1:46:28 PM
291	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/29/2014 1:13:59 PM
290	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/29/2014 12:51:13 PM
289	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/29/2014 11:56:37 AM
288	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/29/2014 11:36:42 AM
287	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/29/2014 10:37:17 AM
286	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/29/2014 10:01:23 AM
285	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/29/2014 9:37:53 AM
284	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/29/2014 9:14:26 AM
283	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/29/2014 8:46:56 AM
282	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/28/2014 3:39:00 PM
281	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/28/2014 3:20:27 PM
280	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/28/2014 2:22:54 PM
279	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	01/28/2014 1:38:34 PM
278	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	01/28/2014 12:15:23 PM
277	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/28/2014 11:36:48 AM
276	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/28/2014 11:05:41 AM
275	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/28/2014 10:19:28 AM
274	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/28/2014 9:58:22 AM
273	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/28/2014 9:32:56 AM
272	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 9:17:32 AM
271	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 8:49:13 AM
270	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/27/2014 3:42:16 PM
269	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/27/2014 3:20:19 PM
268	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/27/2014 3:06:46 PM
267	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/27/2014 2:40:30 PM
266	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/27/2014 2:18:40 PM
265	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/27/2014 2:18:27 PM
264	$NVLX Nuvilex Accelerates Development of	stocklegend	01/27/2014 1:21:09 PM
263	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/27/2014 12:56:23 PM
262	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/27/2014 12:39:03 PM
261	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/27/2014 12:14:16 PM
260	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/27/2014 11:47:21 AM
259	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/27/2014 11:07:24 AM
258	NVLX NEWS:	stocklegend	01/27/2014 10:27:33 AM
257	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/27/2014 9:40:44 AM
256	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/27/2014 9:33:37 AM
255	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/27/2014 9:07:22 AM
254	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/27/2014 8:49:13 AM
253	$NVLX breakout candles called $0.15 PYCKtradr	PoemStone	01/27/2014 7:48:33 AM
252	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/24/2014 11:52:22 AM
251	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/24/2014 11:48:44 AM
250	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/24/2014 10:19:25 AM
249	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/24/2014 9:53:57 AM

Newer

Older

Recent Articles

• RBNZ Implements Significant Rate Cut to Stimulate Recovery
• S.F. Holding Enters Hong Kong Market with Stable Debut
• Mynaric Investors Alert: Legal Options for Shareholder Claims
• Warren Challenges Trump's Funding Tactics and Ethical Standards
• Investigation into Iris Energy: What Investors Need to Know
• Acadia Healthcare Faces Class Action Lawsuit Amid Concerns
• Investors Alert: Join the Toronto-Dominion Bank Class Action
• ASML Holding Investors Alert: Class Action Lawsuit Update
• Visa Investors Alert: Legal Actions and Opportunities for Recovery
• Investors Notified of Class Action Against Hasbro: Important Updates
• Chipotle Investors Can Take Action in Class Action Lawsuit
• Lilium N.V. Faces Legal Scrutiny Amid Financial Challenges
• Key Legal Developments for Celsius Holdings Investors
• Investigation Launched for Toronto-Dominion Bank Shareholders
• PACS Group Investors Urged to Act Amid Class Action Lawsuits
• Important Update for Zeta Global Investors Facing Losses
• Jim Cramer Advocates for Bitcoin and Ethereum as Safe Assets
• Impact of Proposed Tariffs on Energy and Agricultural Commodities
• ARK ETF Adjusts Investment Strategy with Key Stock Moves
• Australia's Inflation Landscape: A Steady Shift in Core Rates
• Global Currency Trends Amid US Economic Outlook: Insights
• New Zealand Central Bank Lowers Cash Rate for Economic Boost
• China's Response to Trump's Tariff Threats Amid Fentanyl Crisis
• Hyundai Motor Receives Positive Outlook from Morgan Stanley
• Investors of China Evergrande Demand Action from Authorities
• Celsius Holdings Faces Legal Challenges Over PepsiCo Deal
• Investigation by Faruqi & Faruqi into ASML Holding after Losses
• Exploring the Future of the Peptide Synthesis Market Growth
• Investors Unite: Leading the Class Action Against Rentokil
• Investors Urged to Explore Rights in Edwards Lifesciences Case
• Investigation Underway for WM Technology Investors Due to Misrepresentation
• Investor Alert: Legal Action Regarding TMC Investigated
• Forecasting Growth in the Personalized Medicines Sector
• Argenta Silver Corp. Updates on Meeting Materials for Shareholders
• Australia's CPI Trends: Inflation Insights Amid Subsidy Support
• ASP Isotopes Faces Scrutiny After Controversial Report
• Wall Street Is Spot On About 2024 Earnings Predictions
• ATRenew Celebrates First Profit Amid Growing Trade-In Trend
• Thanksgiving 2024 Travel: A Surge in Travelers Amid Challenges
• Exploring Legal Paths for Chipotle Investors Facing Losses
• Join the $JENNER Class Action and Protect Your Investment
• Invesque Inc. Approves Major Financial Enhancements for Shareholders
• Eli Lilly & Company Experiences Significant Stock Surge Today
• Investigation Launched into ASP Isotopes Inc. and Its Practices
• JOYY Inc. Updates Their 2024 Financial Performance Insights
• China's Economic Forecast for 2025: Challenges and Opportunities
• Inflation Data: Key Focus for US Stock Market Stability Ahead
• ION Mining Launches Cutting-Edge Mobile App for Enthusiasts
• New Australian Bill Seeks to Protect Children from Social Media
• Investors Standing Against PACS Group's Alleged Misconduct